An exclusive selection of QUALITY Anti-p53 antibodies
targets post translational modification of p53 related to disease development from oncology to Alzheimer’s disease
Fully Validated antibodies developed from world-leading research
Work with us today!
WHAT WE DO
The anti-p53 antibodies originate from the world leading research group studying p53 and the role in disease. The antibodies target changes in the structure of p53 called post translational modifications which can be used as a marker of the disease and as a drug target.
UNIQUE ANTIBODIES
Unique antibodies related to the post translational modification of p53 which has been linked to disease development in a number of areas including oncology and Alzheimer’s disease
RESEARCH AND DEVELOPMENT
Research and drug development of research in the post translation modification area is a target area for many pharmaceutical companies searching for new ways to target disease development.
ABOUT ABBIO
We are biotechnology veterans
With a combined 80 years experienced in manufacturing, drug and diagnostic development.
Our Team
Dr James Clark
CEO
Dr Jean-Christophe Bourdon
CSO
News from our blog
Everything going on over at Abbio!
Contact us
Complete the form below, or reach out via email, phone or social media, to talk to our team today.
contact information
Unit 6, Riverside Court
Mayo Avenue
Dundee
DD2 1XD